The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its ...

Thermo Fisher Scientific raised its annual profit and revenue forecasts on Wednesday, as the medical equipment maker expects ...

Shares of Thermo Fisher Scientific Inc. TMO shed 1.85% to $524.80 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.71% to ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink ® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay ...

Medical equipment maker Thermo Fisher beat analysts' estimates for third-quarter revenue and profit on Wednesday, owing to ...

When Susan Monarez took the helm of the beleaguered US Centers for Disease Control and Prevention (CDC) in late July, she had her work cut out for her. Public trust in the agency had dropped ...

Major stock indexes erased early declines to close higher for a fourth consecutive session Wednesday, shaking off a U.S. government shutdown and a surprising decrease in private-sector jobs.

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced it will present new data on its lead product candidate INO-3107, a potential treatment for Recurrent Respiratory Papillomatosis (RRP), at several ...